Ms. Phoebe Jane Cook is a pharmacist who is specialized in Oncology in Dallas, Texas. Patients can reach her at 3535 Worth St Ste 340, Dallas or contact her on 214-370-1602. Active license number of Ms. Phoebe Jane Cook is 32570 for Oncology in Texas. Ms. Phoebe Jane Cook is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Ms. Phoebe Jane Cook speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Ms. Phoebe Jane Cook
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
3535 Worth St Ste 340, Dallas, Texas, 75246-2006
Phone:
214-370-1602
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Ms. Phoebe Jane Cook are as mentioned below.
NPI Number:
1033280979
NPI Enumeration Date:
13 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ms. Phoebe Jane Cook are as mentioned below.
Specialization
License Number
State
Status
Oncology
32570
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4512 Narrowbrook Dr, Flower Mound, Texas
Zip:
75028-6031
Phone Number:
817-464-0455
Fax Number:
--
Patients can reach Ms. Phoebe Jane Cook at 3535 Worth St Ste 340, Dallas, Texas or can call on phone at 214-370-1602.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.